Madrigal Pharmaceuticals (MDGL) Current Assets (2010 - 2026)
Madrigal Pharmaceuticals (MDGL) posted quarterly Current Assets of $1.2 billion for Q2 2026, up 19.52% year-over-year from $1.0 billion in Q2 2025, and up 1.43% quarter-over-quarter from $1.2 billion in Q1 2026.
Madrigal Pharmaceuticals (MDGL) Current Assets (2010 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has reported Current Assets for 17 consecutive years, with $1.2 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Current Assets rose 19.52% year-over-year to $1.2 billion; the TTM figure through Jun 2026 stood at $1.2 billion (up 19.52% YoY), while the FY2025 annual figure was $1.2 billion, up 20.61% from the prior year.
- Current Assets climbed to $1.2 billion in Q2 2026 per MDGL's latest filing, from $1.2 billion in the prior quarter.
- Across five years, Current Assets topped out at $1.3 billion in Q3 2025 and bottomed at $157.1 million in Q3 2022.
- Historically, Current Assets has averaged $760.4 million across 5 years, with a median of $995.7 million in 2025.
- Annual changes were most pronounced in 2022 — Current Assets slumped 48.14% — and 2024, when it soared 351.72%.
- Madrigal Pharmaceuticals' Current Assets stood at $361.4 million in 2022, then soared by 76.35% to $637.3 million in 2023, then surged by 62.08% to $1.0 billion in 2024, then increased by 20.61% to $1.2 billion in 2025, then fell by 3.74% to $1.2 billion in 2026.
- Business Quant data shows MDGL's Current Assets at $1.2 billion in Q2 2026, $1.2 billion in Q1 2026, and $1.2 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Madrigal Pharmaceuticals | 14.79 Bn | 13.95 Bn | - | 1.20 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.20 Bn |
| Mar 31, 2026 | 1.18 Bn |
| Dec 31, 2025 | 1.25 Bn |
| Sep 30, 2025 | 1.35 Bn |
| Jun 30, 2025 | 1.00 Bn |
| Mar 31, 2025 | 987.98 Mn |
| Dec 31, 2024 | 1.03 Bn |
| Sep 30, 2024 | 1.06 Bn |
| Jun 30, 2024 | 1.09 Bn |
| Mar 31, 2024 | 1.07 Bn |
| Dec 31, 2023 | 637.28 Mn |
| Sep 30, 2023 | 235.47 Mn |
| Jun 30, 2023 | 301.60 Mn |
| Mar 31, 2023 | 331.28 Mn |
| Dec 31, 2022 | 361.37 Mn |
| Sep 30, 2022 | 157.11 Mn |
| Jun 30, 2022 | 214.55 Mn |
| Mar 31, 2022 | 221.17 Mn |
| Dec 31, 2021 | 271.68 Mn |
| Sep 30, 2021 | 302.96 Mn |